Paediatric Subjects - Special Survey

Novo Nordisk A/S71 enrolled

Overview

This study is conducted in Japan. The aim of this study is to collect safety and efficacy data when using insulin aspart in children with diabetes under normal clinical practice conditions.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Interventions

insulin aspartDRUG

Prescribed by the physicians as a result of normal clinical practice

Eligibility

Sex: ALLMax age: 15 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects with diabetes requiring insulin therapy Exclusion Criteria: * Subjects who had treatment history of insulin aspart

Locations (1)

Unnamed facility

Tokyo, Japan

Outcomes

Primary Outcomes

Response rate assessed by the investigator: Ability or failure to achieve expected glycaemic control

Time frame: Year 1

HbA1c (glycosylated haemoglobin)

Time frame: Year 1

Secondary Outcomes

Hypoglycaemic events

Time frame: Year 1

Adverse Events

Time frame: Year 1

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.